DC72634 |
(Rac)-SNC80
|
(Rac)-SNC80 is a racemate of SNC80. SNC80 (NIH 10815) is a potent, highly selective and non-peptide δ-opioid receptor agonist with a Ki of 1.78 nM and an IC50 of 2.73 nM. SNC80 shows antinociceptive, antihyperalgesic and antidepressant‐like effects. SNC80 has the potential for multiple headache disorders treatment. |
DC46693 |
DAMGO
|
DAMGO (DAGO) is a potent and selective μ opioid receptor agonist with ki of 17 nM. |
DC44976 |
LY2940094 tartrate
|
LY2940094 (BTRX-246040) tartrate is a potent, brain penetrant, selective and orally available N/OFQ peptide (NOP) receptor antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY2940094 tartrate reduces Ethanol self-administration and Ethanol seeking in animal models. |
DC41767 |
Nociceptin(1-7) TFA
|
Nociceptin (1-7) TFA is the N-terminal bioactive fragment of nociceptin. Nociceptin (1-7) TFA is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) TFA combines with nociceptin reduces hyperalgesia in vivo.
|
DC41766 |
Nociceptin(1-7)
|
Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin. Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo.
|
DC40982 |
Loperamide phenyl
|
Loperamide phenyl is an impurity of Loperamide. Loperamide is an opioid receptor agonist.
|
DC28780 |
LY2444296
|
LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ∼1 nM. LY2444296 exhibits anti-anxiety like effects. |
DC10290 |
PZM21
|
PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM. |
DC9527 |
Methylnaltrexone (Bromide)
|
Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation.
|
DC9526 |
Meptazinol (hydrochloride)
|
Meptazinol Hcl(WY-22811 Hcl) is a unique centrally active opioid analgesic.
|